Do International Cannabis Companies Deserve More Attention?

Since the legal cannabis industry burst onto investors’ radar in 2014 the U.S. market and the Canadian markets have been the primary focus. The potential of the U.S. market in terms of sheer size, and the Canadian national recreational program and export opportunities have captured investor attention. 

 

Interestingly, there are some U.S. and Canadian companies that are focused on opportunities they see in the emerging markets outside of North America. For example, the European Union medical cannabis market could be worth $64 billion by 2028. Yet, in many cases these companies are undervalued as the overseas operations are largely ignored by investors. 

 

Let’s take a look at three international cannabis opportunities that investors may want to consider as they diversify their portfolio.

 

#1. Aphria is a Dominant Force in Germany

 

Aphria Inc. (TSX: APHA) (NASDAQ: APHA) recently merged with Tilray Inc. (NASDAQ: TLRY) to consolidate operations and compete effectively against larger Canadian companies. The new company expects to compete in the European market and has focused operations on the German market. 

 

2. Isracann Builds Its Footprint in Israel

 

Isracann Biosciences Inc. (CSE: IPOT) is an Israel-based company that aims to become a low-cost producer of high-quality cannabis via its Hefer Valley-based Ein Hahoresh Farm. The company expects to serve the domestic Israeli market, and export cannabis once permitted by Israeli law. 

 

3. Kaya Holdings Takes Successful Model Global


Kaya Holdings Inc. (OTCQB: KAYS) a veteran of the U.S. cannabis business, having launched Oregon operations in 2014, has decided to focus its growth on overseas markets as it waits for the U.S. market to become less fragmented, more competitive and with less regulatory barriers. 

 

Taking their seven years of operational experience, their compelling brands, and their cultivation SOPs, management embarked on a mission to identify and secure viable and practical joint ventures overseas. 

 

To this end, the company acquired a 50% stake in Greece-based Greekkannabis PC (GKC) in January 2021. After receiving its Cannabis Installation License last year, GKC aims to build a 470,000 sq. ft. medical cannabis cultivation and processing facility on 15 acres of land in Thebes, Greece that will have an estimated production capacity of 225,000 pounds of cannabis per year.

 

In addition to its project in Greece, KAYS has been developing Kaya Shalva, a  project that aims to develop a 25-acre plot in Yerucham, Israel to cultivate medical cannabis. 

 

With these two projects, KAYS has the potential to become a key player in the global cannabis sector, able to return to the U.S. market with strength once the U.S. opportunity is ripe. Until then KAYS’ management has expressed plans to keep scouting and vetting international opportunities with an aim to continue to expand its global footprint.  


Diversifying Your Portfolio

 

Despite the promise of the international market, KAYS and other companies have not been granted the value consideration that often gets awarded to companies with such potential. 

 

Cannabis investors may want to consider diversifying their portfolio to include companies engaging the international cannabis markets. Aphria Inc. (NASDAQ: APHA), Isracann Biosciences Inc. (CSE: IPOT), and Kaya Holdings Inc. (OTCQB: KAYS) offer opportunities to do so, although it’s worth noting that KAYS’ strategy of multiple target markets provides the greater diversification opportunity.


Originally Printed by CFN Media.

Comments

Post a Comment

Popular posts from this blog

Kaya Holdings: A Blueprint for Low-Dilution, Low Cost International Expansion

  Many investors seek out two types of opportunities: Value stocks that generate consistent cash flow at a reasonable valuation and Growth stocks that are more risky, but have the prospect of higher returns.    Perhaps an example of a hybrid of the two is  Kaya Holdings Inc.  (OTCQB: KAYS), which has Oregon-based cannabis operations that could provide stable income while the Company develops a number of ambitious overseas projects in Greece and Israel. While management’s international ambitions represent a growth opportunity that could unlock significant shareholder value, there are legitimate concerns of high costs of entry, shareholder dilution and diversion of management attention .   Kaya Holdings may present a mix between value and growth, and with its experienced management team and their responses to investor concerns, investors in both growth and value stocks should pay close attention.   Proven Oregon Model   Kaya Holdings opened its firs...
Read more

Kaya Reaches Beyond Oregon

In early 2014, in a small office in Hollywood, Florida, the management of what is today Kaya Holdings made the strategic decision to transition their existing small-cap publicly traded biofuels company away from alternative energy and exclusively toward the cultivation and retail of legal cannabis. This was no ordinary decision; Colorado and Washington had just launched their legal cannabis programs and no one knew whether a touch-the-plant company would be allowed to remain publicly traded. “After the release of our first public filing we definitely had some ‘hold our breath’ moments as we waited to see what sort of response would come from what could have been seen at the time as our boldness”, remembers W. David Jones, Senior Advisor to KAYS.    To launch their cannabis company, management headed to Oregon because, as CEO Craig Frank put it, “if you want to learn about oil go to Texas, if you want to be on Broadway, go to New York. We wanted to learn about cannabis, so we w...
Read more

Kaya Holdings Makes Progress in International Expansion

Kaya Holdings Inc.  (OTCQB: KAYS) was a pioneer in the U.S. cannabis industry and now sets its sights on high-growth international opportunities in Israel and Greece. After forming Kaya Brands International in September 2019, the company applied for cannabis cultivation and processing licenses in Israel and acquired a 50% stake in a Greece-based cannabis license holder.   By structuring these deals through subsidiaries, the company aims to minimize any dilutive financing for its existing shareholders while capturing the massive upside potential for these projects. The European Union is widely expected to become the world’s largest cannabis market over the next five years with upwards of €123 billion in 2028 sales.   Let’s take a look at the company’s recent progress in advancing these ventures and why investors may want to take a closer look at the stock.   Also see:  Kaya Holdings: A Blueprint for Low-Dilution, Low Cost International Expansion   Securing a...
Read more